Have a personal or library account? Click to login
Neuromidin Attenuates Neuropathic Pain in the Streptozocin-Induced Diabetes Model in Rats Cover

Neuromidin Attenuates Neuropathic Pain in the Streptozocin-Induced Diabetes Model in Rats

Open Access
|Nov 2008

References

  1. Amaral, S., Oliveira, P. J., Ramalho-Santos, J. (2008). Diabetes and the impairment of reproductive function: Possible role of mitochondria and reactive oxygen species. Curr. Diabetes Rev., 4 (1), 46-54.
  2. Aurilio, C., Pota, V., Pace, M. C., Passavanti, M. B., Barbarisi, M. (2008). Ionic channels and neuropathic pain: Physiopathology and applications. J. Cell Physiol., 215(1), 8-14.10.1002/jcp.21280
  3. Bannon, A. W., Decker, M. W., Kim, D. J., Campbell, J. E., Arneric, S. P. (1998). ABT-594, a novel cholinergic channel modulator, is efficacious in nerve ligation and diabetic neuropathy models of neuropathic pain. Brain Res., 801(1-2), 158-163.10.1016/S0006-8993(98)00596-4
  4. Calcutt, N. A., Backonja, M. M. (2007). Pathogenesis of pain in peripheral diabetic neuropathy. Curr. Diab. Rep., 7(6), 429-434.10.1007/s11892-007-0072-9
  5. Cruccu, G. (2007). Treatment of painful neuropathy. Curr. Opin. Neurol., 20(5), 531-535.10.1097/WCO.0b013e328285dfd6
  6. Ezoulin, M. J., Liu, Z., Dutertre-Catella, H., Wu, G., Dong, C. Z., Heymans, F,. Ombetta, J. E., Rat, P., Massicot, F. (2007). A new acetylcholinesterase inhibitor with anti-PAF activity modulates oxidative stress and pro-inflammatory mediators release in stimulated RAW 264.7 macrophage cells. Comparison with tacrine. Int. Immunopharmacol., 7(13), 1685-1694.
  7. Kojima, J., Onodera, K. (1998). NIK-247 induces long-term potentiation of synaptic transmission in the CA1 region of rat hippocampal slices through M2 muscarinic receptors. Gen. Pharmacol., 31(2), 297-300.10.1016/S0306-3623(97)00436-9
  8. Like, A. A., Rossini, A. A. (1976). Streptozocin-induced pancreatic insulitis: New model of diabetes mellitus. Science, 193, 415-417.10.1126/science.180605
  9. Liu, H. C. (2007). Botulinum toxin type a as a prophylactic treatment for chronic daily headache: Time to conduct a large clinical trial in Taiwan? J. Chin. Med. Assoc., 70(12), 519-520.10.1016/S1726-4901(08)70053-4
  10. Lynch, J. J., 3rd., Wade, C. L., Mikusa, J. P., Decker, M. W., Honore, P. (2005). ABT-594 (a nicotinic acetylcholine agonist): Anti-allodynia in a rat chemotherapy-induced pain model. Eur. J. Pharmacol., 509(1), 43-48.10.1016/j.ejphar.2004.12.03415713428
  11. Obata, H., Li X., Eisenach, J. C. (2005). alpha2-Adrenoceptor activation by clonidine enhances stimulation-evoked acetylcholine release from spinal cord tissue after nerve ligation in rats. Anesthesiology, 102(3), 657-662.10.1097/00000542-200503000-0002715731607
  12. Runge-Morris, M., Vento, C. (1995). Effects of streptozotocin-induced diabetes on rat liver sulfotransferase gene expression. Drug Metabol. Dispos., 23(4), 455-459.
  13. Tomlinson, D. R., Gardiner, N. J. (2008). Glucose neurotoxicity. Nat. Rev. Neurosci., 9(1), 36-45.10.1038/nrn229418094705
  14. Tracy, J. A., Dyck, P. J. (2008). The spectrum of diabetic neuropathies. Phys. Med. Rehabil. Clin. N. Amer., 19(1), 1-26.10.1016/j.pmr.2007.10.010272062418194747
  15. Tyagi, E., Agrawal, R., Nath, C., Shukla, R. (2007). Effect of anti-dementia drugs on LPS induced neuroinflammation in mice. Life Sci., 80(21), 1977-1983.10.1016/j.lfs.2007.02.03917395211
  16. Wang, W., Wang, Y. P., Hu, G. Y. (2004). Tetrahydroacridine inhibits voltage-dependent Na(+) current in guinea-pig ventricular myocytes. Acta Pharmacol. Sin., 25(9), 1138-1144.10.1038/s41401-019-0217-9678638530814658
  17. Wong, M. C., Chung, J. W., Wong, T. K. (2007). Effects of treatments for symptoms of painful diabetic neuropathy: Systematic review. BMJ, 335(7610), 87.10.1136/bmj.39213.565972.AE191446017562735
  18. Yoshida, S., Suzuki, N. (1993). Antiamnestic and cholinomimetic side-effects of the cholinesterase inhibitors, physostigmine, tacrine and NIK-247 in rats. Eur. J. Pharmacol., 250(1), 117-124
  19. Ziegler, D. (2008). Treatment of diabetic neuropathy and neuropathic pain: How far have we come? Diabetes Care, 31 Suppl 2, S255-261
  20. Ziegler, D., Ametov, A., Barinov, A., Dyck, P. J., Gurieva, I., Low, P. A., Munzel, U., Yakhno, N., Raz, I., Novosadova, M., Maus, J., Samigullin, R. (2006). Oral treatment with alpha-lipoic acid improves symptomatic diabetic polyneuropathy: The SYDNEY 2 trial. Diabetes Care 29(11), 2365-2370.10.2337/dc06-121617065669
DOI: https://doi.org/10.2478/v10046-008-0024-z | Journal eISSN: 2255-890X | Journal ISSN: 1407-009X
Language: English
Page range: 85 - 90
Published on: Nov 29, 2008
Published by: Latvian Academy of Sciences
In partnership with: Paradigm Publishing Services
Publication frequency: 6 issues per year

© 2008 Vija Kluša, Juris Rumaks, Ñina Karajeva, published by Latvian Academy of Sciences
This work is licensed under the Creative Commons License.

Volume 62 (2008): Issue 3 (June 2008)